STOCK TITAN

Amphastar exec Zhou sells 10,000 shares at $23.94

Amphastar’s Senior EVP exercised 10,000 options and sold 10,000 common shares on September 16, 2026, in a net-sell Form 4 transaction.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Amphastar Pharmaceuticals, Inc. (AMPH) officer Rong Zhou, Senior EVP, Production Center, exercised options for 10,000 shares of common stock on September 16, 2026 at an exercise price of $13.35 per share and sold 10,000 shares the same day at a weighted average price of $23.94. Following the option exercise, Zhou held 19,424 stock options directly, and also has indirect ownership interests in common shares held by the Zhou Family Trust and by the reporting person’s spouse.

Positive

  • None.

Negative

  • None.
Insider Zhou Rong
Role SENIOR EVP, PRODUCTION CENTER
Sold 10,000 shs ($239K)
Approx. gross sale proceeds $239K
Approx. exercise cost $134K
Approx. pre-tax spread $106K
Type Security Shares Price Value
Exercise Employee Stock Option (right to buy) F4 10,000 $0.00 $0.00
Exercise Common Stock 10,000 $13.35 $134K
Sale Common Stock F1 10,000 $23.9404 $239K
holding Common Stock F2 -- -- --
holding Common Stock F3 -- -- --
Holdings After Transaction: Employee Stock Option (right to buy) — 19,424 contracts (Direct); Common Stock — 169,203 shares (Direct); Common Stock — 104,668 shares (Indirect, See footnote)
Footnotes (4)
  1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.83 to $24.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  2. F2. The shares are held of record by the Zhou Family Trust for which the reporting person serves as a trustee.
  3. F3. The shares are held of record by the reporting person's spouse.
  4. F4. Shares subject to the option are fully vested and immediately exercisable.
Options exercised 10,000 shares Employee Stock Options exercised on September 16, 2026
Option exercise price $13.35 per share Exercise price for 10,000 Employee Stock Options
Shares sold 10,000 shares Common stock sale on September 16, 2026
Weighted average sale price $23.9404 per share Sales in a range from $23.83 to $24.05
Options remaining 19,424 shares Stock options held directly after the option exercise
Net shares sold 10,000 shares Net of 10,000 shares acquired via exercise and 10,000 sold
Employee Stock Option (right to buy) financial
"Security title reported as Employee Stock Option (right to buy)"
weighted average price financial
"The price reported is a weighted average price for the sale"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
indirect financial
"Common Stock entry marked as indirect with nature of ownership"
fully vested and immediately exercisable financial
"Shares subject to the option are fully vested and immediately exercisable"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Amphastar (AMPH) executive Rong Zhou report on this Form 4?

Rong Zhou reported exercising 10,000 stock options for Amphastar common stock at $13.35 per share and selling 10,000 shares on September 16, 2026, resulting in a net reported sale of 10,000 shares for that date.

At what prices were the Amphastar (AMPH) shares sold in this Form 4?

The 10,000 shares of Amphastar common stock were sold at a weighted average price of $23.9404 per share, in multiple transactions at prices ranging from $23.83 to $24.05, as disclosed in the footnote.

What was the option exercise price reported by Amphastar (AMPH) executive Rong Zhou?

Rong Zhou exercised 10,000 Employee Stock Options at an exercise price of $13.35 per share, converting them into 10,000 shares of Amphastar common stock before selling those shares the same day.

How many Amphastar (AMPH) options does Rong Zhou hold after the reported transactions?

After exercising 10,000 options on September 16, 2026, Rong Zhou directly held 19,424 stock options on Amphastar common stock, all of which are reported as fully vested and immediately exercisable.

Were the Amphastar (AMPH) transactions under a Rule 10b5-1 trading plan?

No. The Form 4’s Rule 10b5-1 checkbox is not marked as affirmative, and no footnote states that the September 16, 2026 transactions were made pursuant to a Rule 10b5-1 trading plan.

What indirect Amphastar (AMPH) holdings are disclosed for Rong Zhou?

The filing states that some Amphastar common shares are held by the Zhou Family Trust, where Rong Zhou serves as trustee, and by the reporting person’s spouse, indicating indirect ownership interests in those share positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Zhou Rong

(Last)(First)(Middle)
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET

(Street)
RANCHO CUCAMONGA CALIFORNIA 91730

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Amphastar Pharmaceuticals, Inc. [ AMPH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SENIOR EVP, PRODUCTION CENTER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/16/2026M10,000A$13.35179,203D
Common Stock09/16/2026S10,000D$23.9404(1)169,203D
Common Stock99,668ISee footnote(2)
Common Stock5,000ISee footnote(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$13.3509/16/2026M10,000 (4)03/16/2027Common Stock10,000$019,424D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.83 to $24.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
2. The shares are held of record by the Zhou Family Trust for which the reporting person serves as a trustee.
3. The shares are held of record by the reporting person's spouse.
4. Shares subject to the option are fully vested and immediately exercisable.
/s/ Eva Wen, by power of attorney09/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading